Gen-Probe, one of my favorite local biotechs, agrees to cash infusions for Canadian partner DiagnoCure after very promising results on their new prostrate cancer diagnostic. The new diagnostic, which looks for gene PCA3 in urine, has the potential to reduce the high number of biopsies, false positives and unnecessary pain they cause.